πŸ‡ΊπŸ‡Έ FDA
Patent

US 8093267

Methods of treating rheumatoid arthritis

granted A61KA61K31/4164A61P

Quick answer

US patent 8093267 (Methods of treating rheumatoid arthritis) held by LEXICON PHARMACEUTICALS, INC. expires Mon Jan 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
LEXICON PHARMACEUTICALS, INC.
Grant date
Tue Jan 10 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K31/4164, A61P, A61P1/04, A61P11/06